gpl1 vs tirzepatide GLP-1 and Muscle Loss: Semaglutide, & Lean Mass Bridging the gap between GLP1-receptor

Starting with FDA approvals of exenatide in 2005 and liraglutide (Victoza) in 2010, the field accelerated when liraglutide (Saxenda) gained an obesity indication (2014) and semaglutide (Ozempic) was approved for type 2 diabetes (2017)

In this case, a person may benefit from supplementing with the active form of folate

Additionally, Black women have the highest obesity rates of any group

That mechanism could boost metabolism and explain the higher weight loss seen in trials, but more research is needed

Biguanides Biguanides are oral hypoglycemic drugs derived from the Galega officinalis plant, originally developed for the treatment of T2DM